Aller au contenu principal
Profil bibliographique

Iteeshree Mohapatra

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées
401Citations signalées
0Affiliations récentes

Les domaines associés

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapyDNA Repair MechanismsMicroRNA in disease regulationGut microbiota and health

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

A SRC-Annexin A2 axis that couples membrane repair to microRNA export during radiation stress in glioblastoma

Shilpi Singh, Akhilesh Kumar Maurya, Iteeshree Mohapatra, Stefan Kim et autres

ABSTRACT Repair of ionizing-radiation (IR)-induced membrane damage is essential for cell survival, and Annexin A2 (ANXA2) mediates this repair by promoting shedding of microvesicles containing both damaged lipid and ANXA2. Here, we show that coupling this process to microRNA export contributes to …

us, in (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 article OpenAlex

miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma

Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Jay Hou et autres

. Temozolomide (TMZ) treatment induced cross-resistance to radiation and acquired resistance to TMZ; both forms of resistance were eliminated by RAD51 silencing or miR-181d transfection. Finally, the exogenous introduction of miR-181d in an immunocompetent murine glioblastoma model before radiation treatment induced anti-glioblastoma …

us, in (code pays fourni par la source)

2 citations iScience
Accès ouvert 2025 conference-abstract OpenAlex

DDDR-15. miR-181d as a master-regulatory microRNA in glioblastomas that regulates RAD51 and MGMT expression to mediate acquired temozolomide resistance and cross-resistance to ionizing radiation

Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Haoyi Zheng et autres

Abstract BACKGROUND Glioblastoma trials targeting base excision repair (BER) by inhibiting methyl-guanine methyl transferase (MGMT), the key mechanism for repairing temozolomide-induced DNA damage, have yielded disappointing results. One explanation for the disappointing results of these clinical trials of BER inhibitors involves the …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2025 conference-abstract OpenAlex

DNAR-04. Variance in Methyl-guanine methyl transferase (MGMT) expression as a defining feature of intra-tumoral heterogeneity that contribute to acquired temozolomide resistance in glioblastoma

Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Stefan Kim et autres

Abstract BACKGROUND The concepts of mean and variance serve complementary roles in biological research. While the former captures the central tendencies of a trait in populations, the latter defines the degree of spread or dispersion of the data points relative to that …

us (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2025 article OpenAlex

Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance

Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Stefan Kim et autres

Intratumoral heterogeneity plays a pivotal role in cancer evolution, providing the substrate for adaptation to selective pressures, including chemotherapy treatment. Here, we demonstrate that miR-181d modulates variability in methyl-guanine methyl transferase (MGMT) expression, contributing to this heterogeneity in glioblastoma, the most common …

us (code pays fourni par la source)

4 citations Cell Reports
Accès ouvert 2025 article OpenAlex

Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance

Shilpi Singh, Iteeshree Mohapatra, Debashis Barik, Haoyi Zheng et autres

Abstract Glioblastoma remains the most aggressive and treatment-resistant brain malignancy, driven by genetic heterogeneity, metabolic plasticity, and an immunosuppressive tumor microenvironment (TME). Current therapies rely on inducing tumor cell death through DNA damage; however, glioma stem cells (GSCs) upregulate compensatory DNA repair …

us, in (code pays fourni par la source)

36 citations Cell Death Discovery
Accès ouvert 2025 article OpenAlex

Glioblastoma at the crossroads: current understanding and future therapeutic horizons

Shilpi Singh, Devanjan Dey, Debashis Barik, Iteeshree Mohapatra et autres

Glioblastoma (GBM) remains the most aggressive and lethal brain tumor in adults and poses significant challenges to patient survival. This review provides a comprehensive exploration of the molecular and genetic landscape of GBM, focusing on key oncogenic drivers, such as epidermal growth …

us, in (code pays fourni par la source)

270 citations Signal Transduction and Targeted Therapy
Accès ouvert 2025 preprint OpenAlex

Modulating populational variance of methyl-guanine methyl transferase expression through miR-181d degradation: a novel mechanism of temozolomide resistance

Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Stefan Kim et autres

Abstract Intratumoral heterogeneity plays a pivotal role in cancer evolution, providing the substrate for adaptation to selective pressures, including treatment with chemotherapy. Here, we show that micro-RNA regulation of variance in the expression of the DNA repair protein methyl-guanine methyl transferase (MGMT) …

us (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 article OpenAlex

Gut redox and microbiome: charting the roadmap to T-cell regulation

Sujata Prasad, Shilpi Singh, Samuel Menge, Iteeshree Mohapatra et autres

The gastrointestinal (GI) tract redox environment, influenced by commensal microbiota and bacterial-derived metabolites, is crucial in shaping T-cell responses. Specifically, metabolites from gut microbiota (GM) exhibit robust anti-inflammatory effects, fostering the differentiation and regulation of CD8+ tissue-resident memory (TRM) cells, mucosal-associated invariant …

us (code pays fourni par la source)

29 citations Frontiers in Immunology
Accès ouvert 2023 article OpenAlex

Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment

Shilpi Singh, Debashis Barik, Karl Lawrie, Iteeshree Mohapatra et autres

The mTOR signaling pathway plays a pivotal and intricate role in the pathogenesis of glioblastoma, driving tumorigenesis and proliferation. Mutations or deletions in the PTEN gene constitutively activate the mTOR pathway by expressing growth factors EGF and PDGF, which activate their respective …

us, in (code pays fourni par la source)

31 citations International Journal of Molecular Sciences
Accès ouvert 2023 article OpenAlex

Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment

Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, Sujata Prasad et autres

Conventional and cancer immunotherapies encompass diverse strategies to address various cancer types and stages. However, combining these approaches often encounters limitations such as non-specific targeting, resistance development, and high toxicity, leading to suboptimal outcomes in many cancers. The tumor microenvironment (TME) is …

us, in (code pays fourni par la source)

31 citations Biomedicines

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.